# A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Study · id `cardio:ct-nct02097277` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02097277](<https://clinicaltrials.gov/study/NCT02097277>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02097277

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 219 participants.

## Technical summary

Registry record NCT02097277. Randomized; double masking; primary purpose treatment. Start 2014-04-15 (actual); primary completion 2015-09-22 (actual). Results posted on 2019-05-09.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 219 participants (enrolled count; ClinicalTrials.gov record NCT02097277, source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)
- Started: 2014-04-15 (actual) (ClinicalTrials.gov record NCT02097277, source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)
- Primary completion: 2015-09-22 (actual) (ClinicalTrials.gov record NCT02097277, source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)
- Completion: 2016-05-17 (actual) (ClinicalTrials.gov record NCT02097277, source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)
- Results first posted: 2019-05-09 (ClinicalTrials.gov record NCT02097277, source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02097277, source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02097277-2019-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes
- Condition: Diabetes Mellitus Type 2
- Intervention (Biological): BMS-986036
- Intervention (Biological): Placebo (Matching with BMS-986036)
- Lead sponsor: Bristol-Myers Squibb
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Bristol-Myers Squibb (`cardio:org-bristol-myers-squibb`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study (`cardio:pubmed-30520566`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 65328b5f9fd707fa29d07420506442f45a9196f4a055b0244a74c26e4e435180
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
